Nouveau marqueur pour les cancers colorectaux métastatiques
Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy Manceau G1, Imbeaud S, Thiebaut R, Liebaert F, Fontaine K, Rousseau

